Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Mallinckrodt
Moodys
Johnson and Johnson
Medtronic

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)

Docket   Start Trial Date Filed 2011-07-25
Court District Court, D. New Jersey Date Terminated 2012-10-15
Cause 35:271 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Magistrate Judge Douglas E. Ar
Parties ASTRAZENECA AB; ASTRAZENECA LP; HORIZON PHARMA, INC.; KBI-E INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS INC.; POZEN INC.
Patents 5,714,504; 5,900,424; 6,875,872; 6,926,907; 7,745,466
Attorneys CARISSA L. RODRIGUE; ELINA SLAVIN; ERICA SUSAN HELMS; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; KAREN A. CONFOY; KRISTEN HEALEY CRAMER; MARK H. ANANIA; SYMONE J. REDWINE
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. LUPIN LTD.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA AB v. LUPIN LTD. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-07-25 1 The Patents-In-Suit 11. United States Patent No. 5,714,504 (“the ’504 patent”), entitled…of four patents asserted in the matter in controversy: United States Patent Numbers 5,714,504; 6,875,… of the ‘504 patent, the ‘872 patent, the ‘085 patent, the ‘070 patent, the ‘466 patent, and the ‘907… This is a civil action for patent infringement arising under the patent laws of the United States, …United States Patent and Trademark Office on February 3, 1998. The claims of the ’504 patent are directed External link to document
2011-09-26 24 The Patents in Suit ll. Lupin admits that United States Patent No. 5,714,504 (“the ’504 patent”) is …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and …’504 patent, the ’085 patent, the ’872 patent, the ’070 patent, the ’466 patent, the ’907 patent, and External link to document
2011-10-20 34 judgment that U.S. Patent Nos. 5,714,504 (“the ’504 patent”), 6,369,085 (“the ’085 patent”), 6,875,872 (“…’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent,’907 patent, and the ‘424 patent, but…the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent,’907 patent, and ’424 patent, and Plaintiffs…of the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent, and ’907 patent. The remaining… of the ’504 patent, ’085 patent, ’872 patent, ’070 patent, ’466 patent, and ’907 patent and deny the External link to document
2012-07-13 47 Consent Judgment of Non-Infringement of U.S. Patent No. 5,900,424)(FLAHERTY, JOHN) (Entered: 07/13/2012) …2011 15 October 2012 3:11-cv-04275 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Baxter
Medtronic
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.